Evidence map›Paper›PMID 36979439›Full record

ArticleBiomolecules2023

Exploring the Potential of the Model Cyanobacteria

Célia Chenebault, Victoire Blanc-Garin, Marine Vincent, Encarnación Diaz-Santos, Amélie Goudet, Corinne Cassier-Chauvat, Franck Chauvat

Open access · goldFull text read
In one paragraph

Article in Biomolecules, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Célia ChenebaultUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198 Gif-sur-Yvette, France.
Victoire Blanc-GarinUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198 Gif-sur-Yvette, France.ORCID 0000-0002-8139-3306
Marine VincentUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198 Gif-sur-Yvette, France.
Encarnación Diaz-SantosUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198 Gif-sur-Yvette, France.ORCID 0000-0001-6506-8303
Amélie GoudetCEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), Université Paris Saclay, SCBM, 91191 Gif-sur-Yvette, France.
Corinne Cassier-ChauvatUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198 Gif-sur-Yvette, France.ORCID 0000-0001-6901-5559
Franck ChauvatUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198 Gif-sur-Yvette, France.ORCID 0000-0002-9151-7667
Centre National de la Recherche Scientifique · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have performed the first comparative analysis of the potential of two physiologically-diverse model cyanobacteria,

Indexed as

SesquiterpenesSynechococcusSynechocystisLimoneneMonoterpenesTerpenesLimoneneMonoterpenesSesquiterpenesTerpenesbioproductionbisaboleneCyanobacteriafarnesenegenetic engineeringlimonenenitrogen sources (ammonium, nitrate, urea)pinene

Identifiers

PMID36979439
PMCPMC10046388
OpenAlexW4323842615

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read56
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.